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Background: Tick-borne encephalitis virus (TBEV) is a causative agent of acute central nervous system disease in
humans. It has three subtypes, far eastern (FE), Siberian (Sib) and European (Eu) subtypes, which are distributed over
a wide area of Europe and Asia. The objective of this study was to develop a simple and rapid assay for the
detection of TBEV RNA by using reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) method
that can differentiate the three subtypes of TBEV and can be used for clinical diagnosis and epidemiological study.
Methods: Primers for TBEV-specific and subtype-specific RT-LAMP assay were designed to target the consensus
sequence in NS1 of all subtypes and the consensus sequence in the E gene of each subtype, respectiveluy. In vitro
transcribed RNA of Oshima strain that belongs to FE subtype was serially diluted and used to examine the
sensitivity of the assay. Cross-reactivity of subtype-specific RT-LAMP assay was tested by using the RNA of Oshima
and Sofjin (FE), IR-99 (Sib) and Hochosterwitz (Eu) strains. RNA extracted from the mixtures of TBEV and ticks, and of
TBEV and human blood, and the mouse tissues infected with TBEV, were evaluated in the assay. Positive
amplification was observed by real-time monitoring of turbidity and by visual detection of color change.
Results: The sensitivity of TBEV-specific RT-LAMP assay was 102 copies of target RNA per reaction volume. FE-
specific RT-LAMP assay amplified viral genes of Oshima and Sofjin strains but not of IR-99 and Hochosterwitz strains,
and of Japanese encephalitis virus. RT-LAMP assay for Sib and for Eu specifically amplified viral genes of IR-99 and
Hochosterwitz strains, respectively. We also showed that tick or human blood extract did not inhibit the
amplification of viral gene during the assay. Furthermore, we confirmed that the TBEV RT-LAMP could detect virus
RNA from peripheral and central nervous system tissues of laboratory mice infected with TBEV.
Conclusion: TBEV RT-LAMP assay offers a sensitive, specific, rapid and easy-to-handle method for the detection of
TBEV RNA in tick samples and this may be applied in the clinical samples collected from TBE-suspected patients.
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Tick-borne encephalitis virus (TBEV), which belongs to
the genus Flavivirus in the family Flaviviridae, is a
causative agent of acute central nervous system (CNS)
disease in humans and animals [1,2]. Its genomic RNA
consists of one open reading frame and encodes three
structural proteins (C, M and E) and seven nonstructural
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5) [3]. TBEV is transmitted by Ixodes tick species and
rodents in nature, and infects humans through the bite
of an infected tick [1,2,4]. It is distributed over a wide
area of Europe and Asia, and is geographically and
genetically divided into three subtypes, far eastern
(FE), Siberian (Sib) and European (Eu) [5-7]. The vector
of FE and Sib subtypes is Ixodes persulcatus and that of
Eu subtype is Ixodes ricinus [7].
It has been suggested that the FE subtype is associated
with more severe disease than the other subtypes, al-
though the morbidity rate for the disease is different in
Europe and Russia, perhaps at least partly due to a se-
lective registration mostly of severe cases in these areas
[3,7,8]. This raises concern on the risk of tick-borne en-
cephalitis (TBE) in each country or endemic area, where
different TBEV subtypes may be distributed. Therefore,
surveillance on the prevalence of TBEV in ticks or sero-
logical monitoring of rodent is required to assess the risk
of human infection caused by this virus in the endemic
areas [9-11].
In human cases, TBE characteristically takes a biphasic
course involving an acute febrile illness, and a period of
apparent recovery, followed by a neurological syndrome
[2,12]. The neurological symptoms include headache,
meningitis, meningoencephalitis and meningoencepha-
lomyelitis, the latter being observed in the most severe
cases. When death happens, it is usually within 5 to 7 days
from the onset of neurological signs [1]. However, such
clinical features are not unique to TBE, thus, laboratory
diagnosis is required to distinguish it from other neuro-
logical disorders [12,13].
For the surveillance on the prevalence of TBEV in ticks
and other animals, or for clinical diagnosis, molecular
techniques based on genomic detections such as reverse-
transcriptase polymerase chain reaction (RT-PCR) and
real-time RT-PCR (rRT-PCR) have been developed
[10,11,14-19]. However, RT-PCR method requires specific
equipment such as thermal cycler, electrophoresis tank
and UV illuminator. rRT-PCR has some advantages over
conventional RT-PCR and allows high magnitude of amp-
lification, but it requires high-precision instruments for
the amplification and a complicated method for the detec-
tion of amplified products.
The loop-mediated isothermal amplification (LAMP)
assay is a rapid, accurate, and cost-effective diagnostic
method to amplify the DNA under isothermal conditionsat 60°C to 65°C [20,21]. The one-step RT-LAMP assay re-
quires six primers: two inner primers and two outer
primers that define the target region, and two loop
primers for increasing the sensitivity of the assay. The final
DNA products of this assay consist of multiple loops with
several repeats of the target sequence, and can be detected
by agarose-gel electrophoresis, real-time monitoring of
turbidity or visualization of color change. This method
has been used to detect a number of RNA viruses includ-
ing some flaviviruses [22-26]. Its advantage of over RT-
PCR and rRT-PCR is that it makes use of inexpensive and
simple equipment such as a heating block or a water bath.
Thus, the LAMP method has a potential for use as a sim-
ple tool for rapid laboratory confirmation of infectious dis-
ease even in a resource-limiting setting.
In this study, we report the development of one-step
RT-LAMP assay specific to TBEV and to each of the
three subtypes. This assay will be useful in the surveil-
lance of the prevalence of TBEV in ticks and other ani-
mals in the field and in the diagnosis of TBEV infection
in humans.Results
Sensitivity of TBEV-specific RT-LAMP assay
The sensitivity of TBEV-specific RT-LAMP assay that
targets the consensus sequence in NS1 gene of all TBEV
subtypes was examined by using 10-fold serial dilutions
of in vitro transcribed RNA of the FE-subtype Oshima
strain (Figure 1A). The detection limit was 102 copies of
target RNA per reaction volume. All positive amplifica-
tions were achieved in less than 50 min. Agarose gel
electrophoresis of the RT-LAMP products showed the
typical ladder-like pattern of bands (Figure 1B). The
amplified products were confirmed to have the expected
nucleotide sequences (data not shown). Change of color
to cloudy yellow was observed directly by the naked eye
(Figure 1C) and fluorescent detection was observed
under UV irradiation (Figure 1D) in samples with at
least 102 copies. On the other hand, the detection limit
of the TaqMan rRT-PCR assay was 103 copies of target
RNA per reaction volume. Thus, our TBEV-specific RT-
LAMP assay was more sensitive for the transcribed
RNA of the Oshima strain than the rRT-PCR assay with
TBEV-specific primers reported previously [14].TBEV-subtype specific RT-LAMP assay
TBEV-specific RT-LAMP assay could clearly detect viral
gene amplifications for the representative strain (s) of all
subtypes of TBEV used in this study such as Oshima
and Sofjin (FE), IR-99 (Sib) and Hochosterwitz (Eu), but
not for JaOArS982 strain of Japanese encephalitis virus
(JEV) (Figure 2A). All the positive amplifications were
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Figure 1 Gene amplification and detection of the TBEV by TBEV-specific RT-LAMP assay. (A) Real-time kinetics of the RT-LAMP
amplification was monitored by real-time turbidimeter. In vitro transcribed RNA of TBEV Oshima strain was serially diluted to make 10-1 to 104
copies. The reaction was repeated three times and a representative result is shown. (B) Agarose gel electrophoresis profile of the RT-LAMP
products. M indicates 100-bp DNA marker (Sigma). N indicates a sample containing no viral RNA. (C and D) Visual detection of the RT-LAMP
products amplified in a reaction tube. Positive amplification is indicated by change of color to cloudy yellow (C) or by fluorescent green under
UV irradiation (D). (E) Real-time kinetics of TaqMan rRT-PCR with TBEV-specific primer/probe set. In vitro transcribed RNA of Oshima was serially
diluted to make 10-1 to 106 copies. The reaction was repeated three times and a representative result is shown.
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amplify viral genes only of Oshima and Sofjin strains but
not of IR-99 and Hochosterwitz strains, and JEV
(Figure 2B). Sib- and Eu-specific RT-LAMP assay could
amplify viral genes only of IR-99 and Hochosterwitz
strains, respectively, but not of the other subtype strains
and JEV (Figures 2C and 2D). Each subtype-specific RT-
LAMP assay exhibited either similar or shorter reactiontime for positive amplification when compared with
TBEV-specific RT-LAMP assay done in the same RNA
samples (Figure 2). These observations indicate that the
sensitivity of each subtypes-specific RT-LAMP assay was
either similar or higher compared with TBEV-specific
RT-LAMP assay.
rRT-PCR assay using TBEV-specific primers could
clearly detect viral gene amplifications for all subtypes of
A B
C D
































0 10 20 30 40 50 60





















Time (min) Time (min)
Time (min) Time (min)







Figure 2 Gene amplification and detection of different TBEV subtypes by subtype-specific RT-LAMP assay. Real-time kinetics was
monitored by the turbidity of RT-LAMP products after using 10 ng of RNA samples extracted from supernatants of cultured cells infected with the
Oshima (FE), Sofjin (FE), IR-99 (Sib) and Hochostervitz (Eu) strains and JEV JaOArS982 strain. Each viral gene was amplified by (A) TBEV-specific RT-
LAMP assay, (B) TBEV FE subtype-specific RT-LAMP assay, (C) TBEV Sib subtype-specific RT-LAMP assay, or (D) TBEV EU subtype-specific RT-LAMP
assay. Each reaction was repeated three times and a representative result is shown for each sample. (E) Real-time kinetics of TaqMan rRT-PCR with
TBEV-specific primer/probe set using 10 ng of RNA samples extracted from supernatants of cultured cells infected with the Oshima (FE), Sofjin
(FE), IR-99 (Sib) and Hochostervitz (Eu) strains and JEV JaOArS982 strain. The reaction was repeated three times and a representative result
is shown.
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tion than the other strains (Figure 2E). These results in-
dicate that our RT-LAMP assay can specifically amplify
the target RNA of all TBEV subtypes as the rRT-PCR
assay established previously [14].Evaluation of TBEV-specific RT-LAMP assay for
amplification of gene from TBEV mixed with tick
homogenates
Next, we examined the possibility of using the TBEV-
specific RT-LAMP assay for epidemiological study. To
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mixed TBEV Oshima strain prepared at different dilu-
tions (10-1 to 106 pfu) with pooled tick homogenates and
extracted RNA from these mixtures. TBEV-specific RT-
LAMP assay could amplify specific TBEV gene in the
RNA extracted from tick samples with more than 102
pfu of TBEV/10 mg of ticks (Figure 3A). Change of color
to cloudy yellow was visualized in positive samples, but
not in control sample containing no virus (Figure 3B).
These results suggest that tick extract did not inhibit the
amplification of viral gene in the assay.Evaluation of TBEV-specific RT-LAMP assay for
amplification of gene from TBEV mixed with human
blood
To show the possibility of using the TBEV-specific RT-
LAMP assay for clinical diagnosis, we tried to detect the
viral RNA of TBEV Oshima strain mixed in human
blood samples. TBEV-specific RT-LAMP assay could
amplify TBEV gene in the RNA samples extracted from
human blood samples containing more than 101 pfu of
TBEV/200 μl of blood (Figure 4A). Color changed to
cloudy yellow in positive samples, but not in control



















Figure 3 Detection of TBEV gene from a mixture of TBEV and tick ho
monitored by the turbidity of RT-LAMP products after using 10 ng of RNA
(B) Visual detection of color change to cloudy yellow in the RT-LAMP prod
is shown. RNA was extracted from 10 mg of ticks containing TBEV Oshima
Approximately 10 μg of RNA was recovered from one sample.suggest that blood extract did not inhibit the amplifica-
tion of viral gene during the assay.Evaluation of TBEV-specific RT-LAMP assay for detection
of TBEV gene in TBEV-infected mouse tissues
To show the possibility of applying TBEV-specific RT-
LAMP assay for clinical samples, i.e. biopsies samples,
we further attempted to detect the viral RNA in the tis-
sues of laboratory mice infected with TBEV. As we pre-
viously showed, infectious viruses could be detected in
the peripheral tissues 1 to 7 days post-infection (pi) and
in the central nervous system (CNS) 5 days pi [27].
Thus, we collected blood, plasma, liver, spleen and brain
samples of mice infected with the Oshima strain of
TBEV on the 5th and 9th days pi. TBEV-specific RT-
LAMP assay could amplify TBEV RNA in the peripheral
tissues (blood, plasma, liver and spleen) of all mice and
in the brain of one mouse at 5 days pi (Figure 5A and
5B). On the 9th days pi, all mice were positive for TBEV
RNA in their blood and brain. Color change was not vi-
sualized in samples from mock-infected mice at 9 days
pi (Figure 5A and 5B). These results closely reflected the
time course of virus replication in vivo as reported previ-
ously [27].No virus
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Figure 4 Detection of TBEV gene from a mixture of TBEV and human blood by TBEV RT-LAMP assay. (A) Real-time kinetics monitored by
the turbidity of RT-LAMP products after using 10 ng of RNA extracted from each mixture of TBEV and human blood sample. (B) Visual detection
of color change to cloudy yellow in the RT-LAMP products. The reaction was repeated three times and a representative result is shown. RNA was
extracted from 200 μl of blood containing TBEV Oshima strain of different concentrations between 10-1 to 106 pfu. Approximately 2 μg of RNA
was recovered from one sample.



















Figure 5 Detection of TBEV gene from mouse tissue samples by TBEV RT-LAMP assay. Visual detection of RT-LAMP products using 10 ng
of RNA samples extracted from blood, plasma, liver, spleen and brain samples collected from laboratory mice on the 5th and 9th day following
peripheral infections with TBEV Oshima strain. Three mice in each group and one mouse for mock infected mice were used. Positive amplification
was indicated by the change of the color to cloudy yellow (A) or fluorescent green under UV irradiation (B). The reaction was repeated three
times for each sample and a representative result is shown.
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This is the first report of an RT-LAMP assay for detection
of TBEV gene and for differentiating all the three subtypes
(FE, Sib and Eu) of TBEV from each other. We also raised
the possibility that this assay will be useful for the detec-
tion of viral RNA from tick and clinical samples.
Over the last decades, TBE endemic areas and human
cases have increased [7,28], although the disease severity
caused by different subtype of TBEV may vary [3,7,8]. Co-
circulation of the different subtypes exists in some countries,
e.g. Latvia [29]. Therefore, investigation of the distribution of
different subtypes in the field is important for epidemio-
logical studies. In Europe, prevalence of TBEV in ticks is
determined by identifying viral RNA through RT-PCR or
rRT-PCR [10,11,30]. However, the first report on the use of
real-time rRT-PCR [15] could not differentiate between sub-
types. To differentiate TBEV subtype, some techniques have
been developed, e.g. multiplex RT-PCR and pyrosequencing
technique combined with rRT-PCR method [14,17]. How-
ever, PCR-based method has its own disadvantages due to
the high cost of equipment and the requirement for highly
skilled personnel. In this study, we showed that the TBEV
subtype-specific RT-LAMP assay could differentiate sub-
types with high sensitivity. The positive amplification could
be confirmed by simple and direct visualization without the
use of any expensive equipment. Furthermore, we also
showed that tick extract did not inhibit the quality of the
assay. Therefore, this assay might be suitable for the epi-
demiological study of TBEVand in field work.
For current laboratory diagnosis of TBE, serological as-
says are usually used [31,32]. In particular, IgM capture
ELISA has been widely used for rapid diagnosis [33], be-
cause IgM antibody is detected in serum or CSF in the
early phase of disease. However, IgM antibody appears as
late as about two weeks after infection, and can persist for
up to 10 months after vaccination or natural infection of a
person [28]. Viral RNA is detectable before appearance of
IgM antibody. Therefore, PCR-based TBEV diagnosis is
an important alternative to serological methods in the
early phase of the disease [15,19].
Owing to the simple and rapid performance of TBEV RT-
LAMP assay, it has advantages over IgM capture ELISA or
PCR-based TBEV diagnosis. Here, we showed that TBEV
RT-LAMP assay could detect virus RNA from peripheral
and CNS tissues following TBEV infection and was not
inhibited by blood. Therefore, the assay we developed in this
study will be useful for timely diagnosis and rapid laboratory
confirmation of TBE suspected case-patients in TBE en-
demic countries especially in areas with resource-limiting
condition.
Conclusion
In conclusion, the TBEV RT-LAMP assay offers a sensi-
tive, specific, rapid and easy-to-handle method for thedetection of TBEV RNA in clinical samples obtained
from patients during the first phase of their illness or in
tick samples. We hope that this new technique will con-
tribute to practical molecular diagnostic tool as well as
in epidemiological surveillance.
Methods
Design of RT-LAMP assay primers for TBEV
A set of six primers comprising two outer primers (forward
outer primer F3 and backward outer primer B3), two inner
primers (forward inner primer FIP and backward inner pri-
mer LB), and two loop primers (forward loop primer FP
and backward loop primer BP), were designed for the
LAMP assay by using a software PrimerExplorer (version 4;
Eiken Chemical Co., Ltd. Tokyo, Japan). The TBEV-specific
primers were designed to be specific for NS1 gene based on
the consensus sequence identified in 47 strains of TBEV.
On the other hand, the TBEV subtype-specific primers were
designed to be specific to E gene based on each consensus
sequence identified in 63, 96 and 182 strains for FE, Sib
and Eu subtypes, respectively. All primers were synthesized
by Genenet Co., Japan. The details for each primer and the
location in the genomic sequences are shown in the
Table 1.
Cell and virus
Stocks of the Oshima (FE) [34], Sofjin (FE), IR-99 (Sib) [5]
and Hochosterwitz (Eu) strains of TBEV, and JaOArS982
strain of JEV were prepared in baby hamster kidney
(BHK) cells [5,34]. Hochosterwitz strain was kindly pro-
vided by F.X. Heinz (Medical University of Vienna), and
the supernatant of infected BHK cells was kindly provided
by K. Yoshii, (Hokkaido University). Virus titers were de-
termined by plaque forming assays done in BHK cells and
were expressed as pfu/ml [27,35]. The BHK cells were
maintained in Eagle’s Minimal Essential Medium (EMEM;
Nissui Pharmaceutical Co.) containing 10% fetal calf
serum (FCS). All experiments using live TBEV were
performed in a biosafety level 3 laboratory of the Institute
of Tropical Medicine, Nagasaki University according to
standard BSL3 guidelines.
Mice
B6 mice were purchased from Japan SLC Corporation.
Five week old female mice were subcutaneously inocu-
lated with 103 pfu of the Oshima strain of TBEV diluted
in EMEM containing 2% FCS. Mock infected mice were
inoculated with the supernatant medium of uninfected
BHK cells. At 5 and 9 days pi, blood, liver, spleen and
brain samples were collected after euthanasia. Blood
samples were centrifuged to obtain plasma. The animal
experimental protocols were approved by the Animal
Care and Use Committee of the Nagasaki University (ap-
proval number: 100723–1/1008050873).
Table 1 Primer sets designed for RT-LAMP assay detection of TBEV in this study
Primer Sequence Genome position* Length (bp)
TBEV-F3 ACCATAAATGCCGACTGTGA 3319–3338 20
TBEV-B3 TGCCACCACCATTGAGC 3500–3516 17
TBEV-FIP CGGCAGCACCACTCTGGAATTCGGGGGCTTCTGTGAGGA 3345–3361 39
3385–3404
TBEV-BIP TGCACACTACCTCCAGTGACGTGAATTCATGAACAGGACGTATTTCC 3409–3430 47
3462–3480
TBEV-LF ACCTTGCCACTCTCTGTGG 3365–3383 19
TBEV-LB ACGGGGACAGACTGTTGGTATGC 3436–3485 23
FE-F3 TTGACCTTGCTCAGACTGTC 1547–1566 20
FE-B3 CGTCCATTTTCACAGCGTGT 1713–1732 20
FE-FIP TGAACCAGTCCCGGTGGACCTTGGAGCTTGACAAGACCTC 1569–1589 40
1615–1633
FE-BIP GCCCTGCCGTGGAAACATGAGGAGCTCCAAACTCAACCA 1642–1663 39
1694–1710
FE-LF CAGGCCGTCGGTAGGTGTTC 1591–1610 20
FE-LB GGGAGCACAAAACTGGAACA 1662–1681 20
Sib-F3 CCACTCTGGCTGAAGAACAT 1211–1230 20
Sib-B3 ATTGGCGGCAACGTAGTC 1417–1434 18
Sib-FIP GCCCTTTCCAAACAGTCCGCAAGCACGGTGTGCAAGAGAG 1240–1255 40
1285–1305
Sib-BIP TGAGGCAAAGAAGAAGGCCACTCGTGTGTGGCTCAACCTTA 1335–1356 41
1395–1413
Sib-LF CCCAGCCTCGATCACTCTGGT 1256–1276 21
Sib-LB GGACATGTGTATGACGCCAACAAG 1357–1380 24
EU-F3 CGCAAAACTGGAATAACGCA 1667–1686 20
EU-B3 CCACTTCGCAGGTCACATG 1831–1849 19
EU-FIP ACTCCAGTCTGGTCTCCGAGGACTGGTTGAATTTGGGGCTC 1691–1711 41
1741–1760
EU-BIP GTTACTGAAGGCTCTCGCTGGGGCCACTCTTCAGGTGGTACT 1761–1783 42
1811–1829
EU-LF ACACGTCCATCTTGACAGCGT 1715–1735 21
EU-LB GTTCCTGTGGCACACATTGA 1783–1802 20
*genome position is based on the sequence of Neudoerf strain (accession no. TEU27495).
Hayasaka et al. Virology Journal 2013, 10:68 Page 8 of 10
http://www.virologyj.com/content/10/1/68In vitro transcription and quantification
To obtain a quantitative RNA standard with which to
examine the detection limit of RT-LAMP assay, a plasmid
containing full length sequence of the Oshima strain of
TBEV was used for RNA transcription [36]. The plasmid
was digested with Not I and Sma I (Takara) for 1 hour and
the fragment was purified with QIAquick Gel Extraction
Kit (Qiagen). The number of DNA copies/μl was calculated
based on a previous report [37]. The DNA fragment was
then transcribed in vitro with SP6 transcriptase and
digested with DNAse by using mMESSAGE mMACHINE
(Ambion) according to the manufacturer’s protocol. The
RNA was purified with an RNeasy minikit (Qiagen). Thenumber of RNA copies/μl was determined by using the fol-
lowing formula: concentration of RNA (g/μl)/[(transcript
length in nucleotides × 340)] × 6.022 × 1023, where the
RNA length is 4966 base. The RNA concentration was
measured with a NanoDrop ND-1000 apparatus (Thermo
Scientific). The target RNA copy number was calculated
and serial dilutions ranging from 10-1 to 104 RNA copies
were used to determine the range of quantification.
RNA extraction
A 250 μl volume of culture supernatant from infected
BHK cells was mixed with 750 μl of Isogen-LS (Nippon
Gene) and genomic viral RNA was extracted according
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(10-1 to 106 pfu) of the Oshima strain of TBEV were pre-
pared. Each diluted sample was added to 10 mg of
pooled ticks (Ixodes persulcatus, laboratory breeding
ticks was kindly provided by S. Konnai, Hokkaido Uni-
versity) and homogenized in 1 ml of Isogen (Nippon
Gene). A 200 μl volume of healthy human blood was
mixed with 50 μl of the Oshima strain of TBEV pre-
pared at different concentrations (10-1 to 106 pfu) and
with 750 μl of Isogen-LS. RNA was extracted according
to the manufacturer’s protocol. Total RNAs of mouse
blood and plasma samples were extracted using Isogen-
LS (Nippon Gene). Total RNAs of mouse livers, spleens
and brains were extracted using RNeasy Lipid Tissue
Mini Kit (Qiagen) according to the manufacturer’s
protocol. RNA was dissolved in DPEC-treated water and
stored at −80°C until use. The experiment using human
blood was performed with the approval of ethics com-
mittee of the Institute of Tropical Medicine, Nagasaki
University (approval number: 121226102).
RT-LAMP
RT-LAMP was performed in a final reaction volume of
25 μl using a Loopamp RNA amplification kit (Eiken
Chemical Co., Ltd. Tokyo, Japan) with 5 pmol of the
primers F3 and B3, 20 pmol of the primers LF and LB,
and 40 pmol of the primers FIP and BIP. One microliter
of the extracted RNA was used as template per reaction.
The RT-LAMP reaction mixtures were incubated at
62.5°C for 60 min and inactivated at 80°C for 5 min.
Analysis of RT-LAMP product
A real-time turbidity caused by the accumulation of
magnesium polyphosphate was monitored spectrophoto-
metrically at 650 nm with LA-320C Loopamp real-time
turbidimeter (Teramecs, Japan). The results were ana-
lyzed by the LA-320C software package (Teramecs). The
product was electrophoresed on an agarose gel in Tris-
acetate-EDTA (TAE) buffer followed by staining with
ethidium bromide. Amplified products were sequenced
to show that they matched the expected nucleotide se-
quences. Positive amplification was shown by the spe-
cific ladder-like pattern on a UV transilluminator at
320 nm. For visualization of the positive reaction, fluor-
escent detection reagent (FD; Eiken Chemical Co., Ltd.
Tokyo, Japan) was added to the reaction mixture and a
change of color was recognized directly (transparent to
cloudy yellow color) or under UV irradiation (fluores-
cent green).
rRT-PCR
One step rRT-PCR was done with One Step PrimeScriptW
RT-PCR Kit (TAKARA BIO INC.) according to the manu-
facturer’s instructions. TBEV-specific primers and probethat detect all TBEV subtypes described in the previous
paper [14] were synthesized by Genenet Co., Japan. Hy-
drolysis minor groove binder probe (ABI PRISMW
TaqManW MGB probe) was obtained from Applied
Biosystems. The rRT-PCR assay was performed with an
Applied Biosystems 7500 rPCR system. One microliter of
the extracted RNA was used as the template in each reac-
tion mixture. A sample with the growth curve crossing
the threshold line within 40 cycles was considered
positive.
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